Catherine Saez

Catherine Saez

  • Articles: 1423
  • Comments: 1

Antimicrobial Resistance Needs New R&D Models, NGOs Say

A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control.

Chan’s Last Speech To WHA Opening: Affordable Medicines, Innovation, Listen To Civil Society, Partner With Industry

In her final opening speech to the annual World Health Assembly, Director General Margaret Chan today underlined progress made and left to make, and highlighted access to medicines as the most contentious issue of her decade of service. She stressed the importance of innovation, and investment in health, acknowledged the necessity of partners such as the private sector and civil society, and encouraged scientific evidence in decision making. And she focussed strongly on global security and health emergencies.

WIPO Committee On Development Outcome Hailed As Most Positive In Years

After years of mostly discontented discussions at the World Intellectual Property Organization committee on IP and development, last week proved positive, with a 10 year political knot solved, an international conference, and a new project approved, as well as a number of recommendations to implement the 2007 WIPO Development Agenda.

WIPO And The SDGs: Differing Views At Committee On IP And Development

The World Intellectual Property Organization, as a United Nations specialised agency, has a role to play in the implementation of the UN Sustainable Development Goals (SDGs) for the year 2030. How that might happen, and which goals the organisation should pursue are a matter of ongoing discussion at the WIPO Committee on Development and Intellectual Property this week. Views diverge on whether the 17 SDGs should be considered as a whole, of if the organisation should focus on what is considered as its particular expertise and mission.

IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics

The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly.

IP-Watch Guide To 2017 World Health Assembly: Election, Budget, Antibiotics, Cancer, R&D And More

In a few days, the 70th World Health Assembly will open its doors in Geneva with a marathon agenda, and over 4,000 registered delegates. The election of a new director general, the approval of the budget for the next biennium (2018/2019) are set to capture the attention of member states. However, many other subjects require their consideration, such as a resolution on cancer treatment costs, research and development for epidemic diseases, for new antibiotics, for medicines affecting primarily poor populations, access to medicines, and the influenza pandemic preparedness framework.